Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
News NIHR awards £4m to the Birmingham NIHR Clinical Research Facility to enhance research delivery The funding will pay for new research equipment and improve research facilities for patients across the NHS.
News Birmingham Biomedical Research Centre at the University Hospitals Birmingham Research Showcase 2023
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
12 May 2021 Study investigates immune response to SARS-CoV-2 infection in patients with antibody deficiencies A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
11 May 2021 Agents that target viral RNA could be the basis for next generation broad spectrum anti-viral drugs Latest research has found a new approach to tackling viruses by targeting the 'control centre' in viral RNA, leading to broad spectrum anti-viral drugs.
06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.
05 May 2021 Successful virtual conference for global bacterial vaccinology network Over 200 scientists and industry figures worldwide gathered online for the BactiVac Virtual Network Conference 2021 hosted at the University of Birmingham.
21 April 2021 Birmingham Health Innovation Campus takes another step forward after planning permission granted Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
14 April 2021 Over-80s show similar antibody responses following either one Pfizer or AstraZeneca vaccine Latest study finds over-80's receiving a dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.
01 April 2021 Dual dose of the Pfizer COVID-19 vaccine elicits strong antibody immune responses in older people A University of Birmingham-led study has found that 98% of over-80's who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.